IRIS
BILO', Maria Beatrice
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.541
EU - Europa 1.552
AS - Asia 707
AF - Africa 31
OC - Oceania 3
SA - Sud America 2
Totale 9.836
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.535
SG - Singapore 471
IE - Irlanda 419
IT - Italia 253
SE - Svezia 238
UA - Ucraina 202
DE - Germania 160
CN - Cina 151
GB - Regno Unito 88
FR - Francia 86
IN - India 51
RU - Federazione Russa 31
CI - Costa d'Avorio 25
BE - Belgio 19
FI - Finlandia 16
HK - Hong Kong 15
NL - Olanda 10
PL - Polonia 6
KR - Corea 5
CA - Canada 4
CZ - Repubblica Ceca 4
DK - Danimarca 4
JP - Giappone 4
AU - Australia 3
MA - Marocco 3
TW - Taiwan 3
EE - Estonia 2
HR - Croazia 2
HU - Ungheria 2
PK - Pakistan 2
RS - Serbia 2
ZA - Sudafrica 2
AM - Armenia 1
AT - Austria 1
AZ - Azerbaigian 1
EG - Egitto 1
ES - Italia 1
GR - Grecia 1
IR - Iran 1
LA - Repubblica Popolare Democratica del Laos 1
LT - Lituania 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SI - Slovenia 1
Totale 9.836
Salva come PNG Salva come JPEG
Città #
Des Moines 1.770
Chandler 1.018
Fairfield 535
Jacksonville 455
Ashburn 432
Dublin 417
Houston 325
Boardman 277
Woodbridge 248
Wilmington 245
Singapore 217
Cambridge 216
Seattle 203
Lawrence 163
Princeton 163
San Mateo 142
Ann Arbor 123
Redmond 87
San Diego 65
Washington 60
New York 58
Pune 49
Los Angeles 43
London 26
Abidjan 25
Dallas 23
Beijing 20
Centro 19
Brussels 16
Guangzhou 15
Rome 15
Helsinki 14
Falls Church 13
Kilburn 13
Norwalk 13
Cedar Knolls 12
Hong Kong 12
Ancona 10
Milan 10
Shenzhen 10
Shanghai 9
Wuhan 8
Gatchina 7
New Bedfont 6
Prescot 6
Squinzano 6
Turin 6
Hounslow 5
Phoenix 5
St Petersburg 5
Hangzhou 4
Jinhua 4
Marano Vicentino 4
Pescara 4
Redwood City 4
San Severino Marche 4
Santa Clara 4
Wandsworth 4
Amsterdam 3
Bialystok 3
Bologna 3
Civitanova Marche 3
Islington 3
Istia D'ombrone 3
Moscow 3
Perm 3
Rostov-on-Don 3
San Gregorio da Sassola 3
Stockholm 3
Vallefoglia 3
Yiwu 3
Carmignano 2
Central 2
Edinburgh 2
Genoa 2
Heze 2
Jiaxing 2
Jining 2
Kyoto 2
Manchester 2
Montecassiano 2
Monza 2
Napoli 2
Northampton 2
Paris 2
Prague 2
Quanzhou 2
Sioux Falls 2
Southwark 2
Tallinn 2
Tolentino 2
Wuxi 2
Alba 1
Asunción 1
Athens 1
Baku 1
Baoding 1
Belgrade 1
Bolzano 1
Boston 1
Totale 7.761
Salva come PNG Salva come JPEG
Nome #
Idiopathic anaphylaxis 177
Anaphylaxis in Elderly Patients-Data From the European Anaphylaxis Registry 163
The roadmap for the Allergology specialty and allergy care in Europe and adjacent countries. An EAACI position paper 142
Diagnosing, managing and preventing anaphylaxis: Systematic review 137
Rhinopharyngoscopy, computed tomography and magnetic resonance imaging 125
Safety and Adherence to Venom Immunotherapy During COVID-19 Pandemic 111
Cabbage and fermented vegetables: From death rate heterogeneity in countries to candidates for mitigation strategies of severe COVID-19 109
Basal Tryptase High Levels Associated with a History of Arterial Hypertension and Hypercholesterolemia Represent Risk Factors for Severe Anaphylaxis in Hymenoptera Venom-Allergic Subjects over 50 Years Old 101
Sensitization to Cat: Why Not Use Molecular Diagnostics instead of the Nasal Challenge in Clinical Practice? 99
Diagnosis of Immediate-Type ß-Lactam Allergy In Vitro by Flow-Cytometric Basophil Activation Test and Sulfi doleukotriene Production: a Multicenter Study. 97
In vivo diagnosis of allergic diseases - allergen provocation tests 95
Unmet needs and relationship between general practitioners (GPs) and allergists living in Campania region (southern Italy) 93
Why are allergens not detected in the bronchoalveolar lavage fluid of patients undergoing fiberoptic bronchoscopy? Possible explanations 92
Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry 87
Anaphylaxis 87
Oxytocin: a likely underestimated risk for anaphylactic reactions in delivering women sensitized to latex 86
Severe asthma in adults does not significantly affect the outcome of COVID-19 disease: Results from the Italian Severe Asthma Registry 86
Prevention and treatment of hymenoptera venom allergy: Guidelines for clinical practice 85
Phenotype and risk factors of venom-induced anaphylaxis: a case-control study of the European Anaphylaxis Registry 84
Contraindications to immunotherapy: A global approach 83
Fatal anaphylaxis in Italy: Analysis of cause-of-death national data, 2004-2016 82
Immunotherapy for hymenoptera venom allergy: too expensive for European health care? 82
Forced oscillation technique as method to document and monitor the efficacy of mepolizumab in treating severe eosinophilic asthma 81
Clinical aspects of hymenoptera venom allergy and venom immunotherapy 80
World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis 80
Precision Medicine in Hymenoptera Venom Allergy: Diagnostics, Biomarkers, and Therapy of Different Endotypes and Phenotypes 80
Anaphylaxis to baobab fruit: The paradox of “natural healthy food” 79
Bonifazi F. Epidemiology of Hymenoptera sting anaphylaxis 78
European hornet (Vespa crabro) sting: a new risk factor for life-threatening reaction in hymenoptera allergic patients? 78
Large local reactions to Hymenoptera stings: outcome of re-stings in real-life 77
Development of a model care pathway for the management of Hymenoptera venom allergy: Evidence-based key interventions and indicators 77
Skin test concentrations for systemically administered drugs -- an ENDA/EAACI Drug Allergy Interest Group position paper 77
Is diet partly responsible for differences in COVID-19 death rates between and within countries? 77
World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings 76
The natural history and epidemiology of insect venom allergy: clinical implications 75
Detection of Gibberellin-Regulated Protein (Peamaclein) Sensitization among Italian Cypress Pollen-Sensitized Patients 75
Diagnosis of Hymenoptera venom allergy 75
EAACI anaphylaxis guidelines: Systematic review protocol 74
Anisakis hypersensitivity in Italy: prevalence and clinical features: a multicenter study. 74
Editorial: Anaphylaxis – A Distinct Immunological Syndrome, but How Much Do We Really Understand? 73
The role of component-resolved diagnosis in Hymenoptera venom allergy 73
Advances in Hymenoptera venom immunotherapy 73
Mast cell diseases and the severity and course of intraoperative anaphylaxis 71
Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: the importance of baseline serum tryptase 71
Congruence between international guidelines and mite specific immunotherapy prescribing practices 70
Sublingual immunotherapy with venom is not recommended for patients with Hymenoptera venom allergy 70
Anaphylaxis caused by Hymenoptera stings: from epidemiology to treatment 70
Allergen-specific immunotherapy provides immediate, long-term and preventive clinical effects in children and adults: the effects of immunotherapy can be categorised by level of benefit -the centenary of allergen specific subcutaneous immunotherapy 70
Risk Factors and Characteristics of Biphasic Anaphylaxis 70
Antigen 5 Allergens of Hymenoptera Venoms and Their Role in Diagnosis and Therapy of Venom Allergy 69
Allergen immunotherapy for insect venom allergy: protocol for a systematic review 68
Shedding Light on the Venom Proteomes of the Allergy-Relevant Hymenoptera Polistes dominula (European Paper Wasp) and Vespula spp. (Yellow Jacket) 67
Clinical effectiveness of hymenoptera venom immunotherapy: a prospective observational multicenter study of the European academy of allergology and clinical immunology interest group on insect venom hypersensitivity 67
A prevalent exposure to male dog is a risk factor for exclusive allergic sensitization to Can f 5: An Italian multicenter study 66
Safety of a 2-day ultrarush immunotherapy in vespid allergic patients: Focus on elevated serum tryptase 65
High long-term efficacy of venom immunotherapy after discontinuation 65
World Allergy Organization anaphylaxis guidelines: Summary 65
Honeybee venom immunotherapy: a comparative study using purified and nonpurified aqueous extracts in patients with normal Basal serum tryptase concentrations 65
Epidemiology of hymenoptera allergy 65
Anaphylaxis in children and adolescents: The European Anaphylaxis Registry 64
Anxiety and depression in adolescents with asthma and in their parents. Is an increased basal cholinergic tone a possible further reason to explain the negative impact on asthma control? 64
The VISYT trial: Venom Immunotherapy Safety and Tolerability with purified vs nonpurified extracts 64
First European data from the network of severe allergic reactions (NORA) 64
Insect sting anoxic encephalopathy after stopping venom immunotherapy. 64
Hymenoptera Venom Allergy - European Academy of Allergy and Clinical Immunology Monographs 63
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy 63
Purified vs. nonpurified venom immunotherapy 63
Treating venom allergy during COVID-19 pandemic 63
Hymenoptera Venom Immunotherapy: How to Safely Switch to the Same Venom From a Different Manufacturer 62
International consensus on (ICON) anaphylaxis 62
Use of adrenaline in allergy 62
Hyposensitization therapy of Parietaria-sensitive patients with a tyrosine adsorbed allergoid, Pollinex Parietaria (Bencard Parietaria) 62
Epinephrine in Severe Allergic Reactions: The European Anaphylaxis Register 61
Omalizumab in chronic spontaneous urticaria: patient-tailored tapering or planned discontinuation? 61
Anxiety/depression and impaired asthma control in adolescents. Is an increased basal cholinergic tone a possible link ? 61
Shortness of interval between two stings as risk factor for developing Hymenoptera venom allergy 61
Ves v 5 can establish the diagnosis in patients without detectable specific IgE to wasp venom and a possible north-south difference in Api m 1 sensitization in Europe 61
Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase-a study of the European Academy of Allergology and Clinical Immunology Interest Group on Insect Venom Hypersensitivity 61
Oxytocin: an unexpected risk for cardiologic and broncho-obstructive effects, and allergic reactions in susceptible delivering women 61
CAP-Inhibition, Molecular Diagnostics, and Total IgE in the Evaluation of Polistes and Vespula Double Sensitization 60
High adherence to hymenoptera venom subcutaneous immunotherapy over a 5-year follow-up: A real-life experience 60
Lysozyme, a new allergen in donkey's milk 59
Efficacy of a single dose of omalizumab for the prevention of ethylene oxide intraoperative anaphylaxis 59
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be Suspected 59
Clonal mast cell disorders in patients with severe Hymenoptera venom allergy and normal serum tryptase levels 59
European Polistes venom allergy 58
Diagnosis of immediate-type beta-lactam allergy in vitro by flow-cytometric basophil activation test and sulfidoleukotriene production: a multicenter study 58
Reducing the risk of anaphylaxis during anesthesia: 2011 updated guidelines for clinical practice 58
Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy Reply 57
Component resolved diagnosis in real life: the risk assessment of food allergy using microarray-based immunoassay 57
Allergen immunotherapy for insect venom allergy: a systematic review and meta-analysis 56
Honeybee venom immunotherapy: certainties and pitfalls 56
Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from The European Anaphylaxis Registry 55
Adherence to the rhinitis management plan of allergic rhinitis 55
Efficacy of an air‐cleaning device equipped with a high efficiency particulate air filter in house dust mite respiratory allergy 55
Risk of severe anaphylaxis for patients with Hymenoptera venom allergy: Are angiotensin-receptor blockers comparable to angiotensin-converting enzyme inhibitors? Reply 55
2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis 55
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies 54
Vespid allergy 54
EAACI Food Allergy and Anaphylaxis Guidelines Group. Management of anaphylaxis: a systematic review 53
Totale 7.428
Salva come PNG Salva come JPEG
Categoria #
all - tutte 62.855
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.855
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020484 0 0 0 0 0 96 33 8 51 6 122 168
2020/20212.127 116 179 260 87 430 113 114 180 191 143 221 93
2021/20221.200 61 235 18 35 21 69 46 94 106 75 132 308
2022/20234.055 228 212 169 261 177 1.998 1 167 588 23 166 65
2023/20241.392 268 39 119 139 223 271 23 46 7 53 19 185
2024/2025722 100 232 100 74 63 153 0 0 0 0 0 0
Totale 10.125